Multiple Myeloma Coverage from Every Angle

Edward A. Stadtmauer, MD, on CRISPR-Edited T Cells for Multiple Myeloma

Posted: Friday, January 17, 2020

Edward A. Stadtmauer, MD, of the University of Pennsylvania Abramson Cancer Center, describes his early findings and explains how this work might eventually lead to novel approaches for patients with heavily pretreated multiple myeloma and sarcoma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.